An observational study in Stillbirth, sponsored by University of Witwatersrand, South Africa. Completed at 2 sites in South Africa. Open to participants aged Up to 1 Day. Per ClinicalTrials.gov, last updated 2024-05-28.
Sponsored by University of Witwatersrand, South Africa · Observational
This is a descriptive study to determine the role of fetal GBS disease as a cause for stillbirths
A prospective, descriptive study will be undertaken involving mothers who have a stillbirth at Chris Hani Baragwanath Academic Hospital (CHBAH), a secondary-tertiary care hospital, from 2014 up until 2016.
121 studies on the registry are indexed under Stillbirth; 34 are open to participants now.
This study's enrollment of 354 is below the median of 794 across 52 observational studies indexed under Stillbirth.
Browse Stillbirth studies →University of Witwatersrand, South Africa is the lead sponsor of 47 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Stillborn infants (gestational age >= 28 weeks gestation) born at CHBAH
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Determine the number of stillbirths who have GBS isolated from cord blood, gastric aspirates, placenta and/ or skin swabs
Time frame: Birth
Number of stillbirths occurring at CHBAH, and identify potential causes of the stillbirths (maternal and obstetric risk factors)
To determine the epidemiology of stillbirths, including identification of maternal risk-factors
Time frame: Birth
Number of stillbirths related to a probable Infectious cause
To determine the proportion of stillbirths that are associated with common fetal in-utero infections including; Syphilis (Treponema pallidum), Klebsiella sp, E. Coli
Time frame: Birth
This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Witwatersrand, South Africa